Moderna’s updated RSV vaccine disappoints with only 50% efficacy

Moderna reported that its vaccine was 50% effective at preventing lower respiratory disease following RSV infection, falling short of numbers reported by GSK and Pfizer …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Docs Decry ICU Closure; Outpatient Facility Fees; Hospitals Eye Sports Centers

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Clinicians Protest ICU Closure at Minnesota

March 28, 2024

Could pizza consumption improve rheumatoid arthritis severity?

Investigating whether pizza and its ingredients modulated RA disease activity.

August 8, 2023

Lunaphore and Acd Revolutionize Spatial Biology Research With the Launch of the First Fully Automated, Same-Section, Hyperplex Multiomics Application

Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics (ACD), will launch the first fully automated spatial multiomics

January 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.